36 results on '"Lemstra, Evelien"'
Search Results
2. Psychosocial Effects of COVID-19 Measures on (Pre-)Dementia Patients During Second Lockdown
3. Acute response to cholinergic challenge predicts long‐term response to galantamine treatment in patients with Alzheimer's disease
4. Psychosocial effects of Corona virus measures on (pre‐)dementia patients during 2 nd lockdown
5. Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's Disease
6. Mild cognitive impairment with Lewy bodies: Clinical characteristics and risk factors for progression
7. Relationship between clinical symptomatology and disease burden in dementia with Lewy bodies: An overview of the DEvELOP baseline results
8. Psychosocial Effects of Corona Measures on Patients With Dementia, Mild Cognitive Impairment and Subjective Cognitive Decline
9. Different combinations of diagnostic tests discriminate specific subtypes of dementia
10. O3-12-06: NOVEL CSF PROTEIN BIOMARKERS FOR SPECIFIC AND DIFFERENTIAL DIAGNOSIS OF AD
11. DATA-DRIVEN DIAGNOSIS OF DEMENTIA DISORDERS: THE PREDICTND VALIDATION STUDY
12. P1‐357: MEDIAN SURVIVAL IN MEMORY CLINIC COHORT IS SHORT, EVEN IN YOUNG‐ONSET DEMENTIA
13. P2‐349: DIFFERENT COMBINATIONS OF DIAGNOSTIC TESTS DISCRIMINATE SPECIFIC SUBTYPES OF DEMENTIA
14. [P1–375]: DATA‐DRIVEN DIAGNOSIS OF DEMENTIA DISORDERS: THE PREDICTND VALIDATION STUDY
15. NOVEL CSF PROTEIN BIOMARKERS FOR SPECIFIC AND DIFFERENTIAL DIAGNOSIS OF AD
16. DIFFERENT COMBINATIONS OF DIAGNOSTIC TESTS DISCRIMINATE SPECIFIC SUBTYPES OF DEMENTIA
17. MEDIAN SURVIVAL IN MEMORY CLINIC COHORT IS SHORT, EVEN IN YOUNG-ONSET DEMENTIA
18. O2-08-06: THE FUTURE OF CARE: THE DIGITAL ALZHEIMER CENTER-EVALUATION OF AN ONLINE PORTAL FOR PATIENTS WITH DEMENTIA AND THEIR INFORMAL CAREGIVERS
19. P4-163: TRAJECTORIES OF COGNITIVE DECLINE IN VARIOUS TYPES OF DEMENTIA
20. O1-09-01: Diagnostic impact of CSF biomarkers for Alzheimer's disease in a memory clinic setting
21. P3–281: Response to an acute pharmacological challenge with galantamine as a predictor for responsiveness to long‐term treatment
22. P2-094: The role of ASL-measured cerebral blood flow in the differential diagnosis of Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies
23. IC-P-062: The role of ASL-measured cerebral blood flow in the differential diagnosis of Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies
24. Psychosocial effects of Corona virus measures on (pre‐)dementia patients during 2nd lockdown.
25. O4-09-02: Diagnostic value of molecular imaging in a memory clinic setting
26. P3-263: CSF alpha-synuclein is not diagnostic for dementia with Lewy bodies, but related to cognitive decline
27. P4-158: The association of neuroleptic sensitivity in Lewy body disease with a false positive clinical diagnosis of Creutzfeldt-Jakob disease
28. P1-438: Cholinergic deficiency syndrome as indicator for cholinesterase inhibitor therapy
29. THE FUTURE OF CARE: THE DIGITAL ALZHEIMER CENTER–EVALUATION OF AN ONLINE PORTAL FOR PATIENTS WITH DEMENTIA AND THEIR INFORMAL CAREGIVERS
30. Evaluation of the effects of therapy in individual patients with Alzheimer's disease; limitations and opportunities
31. Diagnostic impact of CSF biomarkers for Alzheimer's disease in a memory clinic setting
32. Response to an acute pharmacological challenge with galantamine as a predictor for responsiveness to long-term treatment
33. The role of ASL-measured cerebral blood flow in the differential diagnosis of Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies
34. Diagnostic value of molecular imaging in a memory clinic setting
35. CSF alpha-synuclein is not diagnostic for dementia with Lewy bodies, but related to cognitive decline
36. [Role of secondary care too small in Dutch College of General Practitioners' (NHG) practice guideline 'Dementia'].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.